Title

Food and Drug Committee FDA Flash! - Genentech Sues Amgen under the BPCIA Regarding Amgen's Disclosures for its Biosimilar of Avastin

Announcement Description

​Check out our new FDA Flash! article, Genentech Sues Amgen under the BPCIA Regarding Amgen's Disclosures for its Biosimilar of Avastin, by Laura W. Smalley, Partner, Harris Beach PLLC (Mar. 1, 2017).

Expires

 

Attachments

Created at 3/13/2017 9:06 AM by Shana Cyr
Last modified at 3/13/2017 9:06 AM by Shana Cyr